Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma. (Q51530246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

Markus Peck-Radosavljevic

13 February 2020

author

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Thomas Gruenberger

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

4

Markus Reiter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Wolfgang Sieghart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Claus Kölblinger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Martin Schindl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Gregor Ulbrich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Rudolf Steininger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Christian Müller

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Rudolf Stauber

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Maximilian Schöniger-Hekele

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Manfred Gschwendtner

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Christina Plank

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Martin Funovics

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ivo Graziadei

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Johannes Lammer

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Günther Gastl

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Franz Karnel

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Austrian Association of Gastroenterology,Hepatology (ÖGGH)

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Austrian Society of Interventional Radiology (ÖGIR)

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Austrian Society of Hematology and Oncology (ÖGHO)

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Austrian Society for Surgical Oncology (ASSO)

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

22 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

published in

Vienna Clinical Weekly

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

104-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00508-011-0056-2

13 February 2020

exact match

0 references

cites work

Loco-regional treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Transcatheter oily chemoembolization of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-011-0056-2

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents

1 reference

12 December 2020

Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.

1 reference

12 December 2020

Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies

1 reference

12 December 2020

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

1 reference

12 December 2020

Usefulness of cone-beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiography

1 reference

12 December 2020

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

12 December 2020

Re: Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies

1 reference

12 December 2020

Chemoembolization for unresectable hepatocellular carcinoma in Japan

1 reference

12 December 2020

Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy

1 reference

12 December 2020

Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study

1 reference

12 December 2020

10.1007/S00508-011-0056-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21935644%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference